AIRNA Bio Germany GmbH

AIRNA Bio Germany GmbH is a wholly owned subsidiary of AIRNA Bio, a US biotech company focusing on a unique RNA-targeting strategy. We develop a novel class of oligonucleotides to enable RNA base editing for changing genetic information. Our vision is to make our technology available to patients with orphan or common diseases where only limited treatment options exist. AIRNA Bio Germany is located in Tübingen, Germany, a renowned place for innovations and successful start-up stories.